Annual Shareholders Equity
$457.60 M
+$119.06 M+35.17%
31 December 2023
Summary:
ANI Pharmaceuticals annual stockholders equity is currently $457.60 million, with the most recent change of +$119.06 million (+35.17%) on 31 December 2023. During the last 3 years, it has risen by +$261.90 million (+133.83%). ANIP annual shareholders equity is now at all-time high.ANIP Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$430.80 M
-$49.81 M-10.36%
30 September 2024
Summary:
ANI Pharmaceuticals quarterly stockholders equity is currently $430.80 million, with the most recent change of -$49.81 million (-10.36%) on 30 September 2024. Over the past year, it has dropped by -$23.91 million (-5.26%). ANIP quarterly shareholders equity is now -10.36% below its all-time high of $480.61 million, reached on 30 June 2024.ANIP Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIP Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.2% | -5.3% |
| 3 y3 years | +133.8% | +125.1% |
| 5 y5 years | +132.0% | +102.1% |
ANIP Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +133.8% | -10.4% | +125.1% |
| 5 y | 5 years | at high | +133.8% | -10.4% | +125.1% |
| alltime | all time | at high | >+9999.0% | -10.4% | >+9999.0% |
ANI Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $430.80 M(-10.4%) |
| June 2024 | - | $480.61 M(+0.8%) |
| Mar 2024 | - | $476.81 M(+4.2%) |
| Dec 2023 | $457.60 M(+35.2%) | $457.60 M(+0.6%) |
| Sept 2023 | - | $454.71 M(+4.7%) |
| June 2023 | - | $434.47 M(+28.0%) |
| Mar 2023 | - | $339.48 M(+0.3%) |
| Dec 2022 | $338.54 M(-5.6%) | $338.54 M(+0.6%) |
| Sept 2022 | - | $336.68 M(-0.1%) |
| June 2022 | - | $336.96 M(-2.6%) |
| Mar 2022 | - | $346.09 M(-3.5%) |
| Dec 2021 | $358.74 M(+83.3%) | $358.74 M(+87.4%) |
| Sept 2021 | - | $191.40 M(-0.3%) |
| June 2021 | - | $191.92 M(-5.8%) |
| Mar 2021 | - | $203.71 M(+4.1%) |
| Dec 2020 | $195.70 M(-8.0%) | $195.70 M(+0.3%) |
| Sept 2020 | - | $195.10 M(+2.0%) |
| June 2020 | - | $191.34 M(-4.9%) |
| Mar 2020 | - | $201.17 M(-5.5%) |
| Dec 2019 | $212.79 M(+7.9%) | $212.79 M(-0.2%) |
| Sept 2019 | - | $213.13 M(+2.6%) |
| June 2019 | - | $207.66 M(+4.0%) |
| Mar 2019 | - | $199.71 M(+1.2%) |
| Dec 2018 | $197.26 M(+12.9%) | $197.26 M(+2.5%) |
| Sept 2018 | - | $192.47 M(+4.0%) |
| June 2018 | - | $185.11 M(+3.0%) |
| Mar 2018 | - | $179.64 M(+2.8%) |
| Dec 2017 | $174.76 M(+3.0%) | $174.76 M(-4.4%) |
| Sept 2017 | - | $182.80 M(+3.5%) |
| June 2017 | - | $176.55 M(+2.5%) |
| Mar 2017 | - | $172.21 M(+1.5%) |
| Dec 2016 | $169.65 M(+6.0%) | $169.65 M(+0.5%) |
| Sept 2016 | - | $168.83 M(+3.1%) |
| June 2016 | - | $163.78 M(+2.2%) |
| Mar 2016 | - | $160.18 M(+0.1%) |
| Dec 2015 | $160.08 M(+14.5%) | $160.08 M(+2.7%) |
| Sept 2015 | - | $155.89 M(+4.3%) |
| June 2015 | - | $149.50 M(+3.3%) |
| Mar 2015 | - | $144.74 M(+3.5%) |
| Dec 2014 | $139.78 M(+241.3%) | $139.78 M(+40.5%) |
| Sept 2014 | - | $99.49 M(+8.6%) |
| June 2014 | - | $91.59 M(-0.5%) |
| Mar 2014 | - | $92.09 M(+124.8%) |
| Dec 2013 | $40.96 M(+45.4%) | $40.96 M(+11.6%) |
| Sept 2013 | - | $36.69 M(+3.4%) |
| June 2013 | - | $35.49 M(+36.4%) |
| Mar 2013 | - | $26.03 M(-7.6%) |
| Dec 2012 | $28.18 M | $28.18 M(-12.7%) |
| Sept 2012 | - | $32.29 M(+4.4%) |
| June 2012 | - | $30.92 M(-18.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $38.00 M(+0.5%) |
| Dec 2011 | $37.82 M(+97.5%) | $37.82 M(-14.3%) |
| Sept 2011 | - | $44.15 M(+282.9%) |
| June 2011 | - | $11.53 M(-55.9%) |
| Mar 2011 | - | $26.14 M(+36.5%) |
| Dec 2010 | $19.15 M(+21.0%) | $19.15 M(+25.1%) |
| Sept 2010 | - | $15.30 M(-42.5%) |
| June 2010 | - | $26.63 M(+15.7%) |
| Mar 2010 | - | $23.01 M(+45.3%) |
| Dec 2009 | $15.83 M(+14.5%) | $15.83 M(+41.6%) |
| Sept 2009 | - | $11.18 M(+92.4%) |
| June 2009 | - | $5.81 M(-42.5%) |
| Mar 2009 | - | $10.11 M(-26.9%) |
| Dec 2008 | $13.83 M(-53.5%) | $13.83 M(-9.3%) |
| Sept 2008 | - | $15.25 M(-26.4%) |
| June 2008 | - | $20.71 M(-19.7%) |
| Mar 2008 | - | $25.79 M(-13.2%) |
| Dec 2007 | $29.73 M(+64.5%) | $29.73 M(-4.7%) |
| Sept 2007 | - | $31.18 M(-4.2%) |
| June 2007 | - | $32.54 M(+95.8%) |
| Mar 2007 | - | $16.62 M(-8.0%) |
| Dec 2006 | $18.07 M(+165.0%) | $18.07 M(+100.1%) |
| Sept 2006 | - | $9.03 M(+250.2%) |
| June 2006 | - | $2.58 M(-45.1%) |
| Mar 2006 | - | $4.69 M(-31.2%) |
| Dec 2005 | $6.82 M(-57.2%) | $6.82 M(-25.7%) |
| Sept 2005 | - | $9.18 M(-16.1%) |
| June 2005 | - | $10.94 M(-18.3%) |
| Mar 2005 | - | $13.40 M(-15.9%) |
| Dec 2004 | $15.92 M(+83.3%) | $15.92 M(-19.3%) |
| Sept 2004 | - | $19.73 M(-11.0%) |
| June 2004 | - | $22.17 M(+194.7%) |
| Mar 2004 | - | $7.52 M(-13.4%) |
| Dec 2003 | $8.68 M(+87.8%) | $8.68 M(-14.8%) |
| Sept 2003 | - | $10.20 M(+405.0%) |
| June 2003 | - | $2.02 M(-40.2%) |
| Mar 2003 | - | $3.38 M(-26.9%) |
| Dec 2002 | $4.62 M(+14.1%) | $4.62 M(-9.1%) |
| Sept 2002 | - | $5.09 M(+261.7%) |
| June 2002 | - | $1.41 M(-52.3%) |
| Mar 2002 | - | $2.95 M(-27.3%) |
| Dec 2001 | $4.05 M(+90.6%) | $4.05 M(-25.8%) |
| Sept 2001 | - | $5.46 M(+27.9%) |
| June 2001 | - | $4.27 M(-11.8%) |
| Mar 2001 | - | $4.84 M(+127.8%) |
| Dec 2000 | $2.13 M(-61.0%) | $2.13 M(-29.8%) |
| Sept 2000 | - | $3.03 M(-15.5%) |
| June 2000 | - | $3.58 M(-28.4%) |
| Mar 2000 | - | $5.01 M |
| Dec 1999 | $5.45 M(+107.1%) | - |
| Dec 1998 | $2.63 M | - |
FAQ
- What is ANI Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual shareholders equity year-on-year change?
- What is ANI Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly shareholders equity year-on-year change?
What is ANI Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of ANIP is $457.60 M
What is the all time high annual shareholders equity for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual stockholders equity is $457.60 M
What is ANI Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, ANIP annual stockholders equity has changed by +$119.06 M (+35.17%)
What is ANI Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of ANIP is $430.80 M
What is the all time high quarterly shareholders equity for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly stockholders equity is $480.61 M
What is ANI Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, ANIP quarterly stockholders equity has changed by -$23.91 M (-5.26%)